UTI Healthcare Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹815 Cr | ₹1150 Cr |
Min Investment | ₹1000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 10 Jul 2019 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 31% | 28% |
Expense Ratio | 2.27 | 2.22 |
Manager | Dhaval Joshi | Kamal Gada |
ISIN Code | INF209KB1N91 | INF789F01695 |
Exits Load | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | 2.04% | 0.71% |
6 Month | -3.07% | -3.47% |
1 Year | 14.46% | 20.58% |
3 Year | 18.55% | 20.15% |
5 Year | 19.55% | 21.99% |
SIP Return Analysis
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 0.15% | -0.9% |
1 Year | 0.87% | 3.76% |
3 Year | 23.1% | 25.8% |
5 Year | 18.04% | 19.85% |
Rolling Lumpsum Returns
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 29.31% | 11.43% |
3 Year | 15.89% | 16.02% |
5 Year | 24.32% | 14.18% |
Risk Management
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 16.061% | 16.371% |
Sharp | 0.719% | 0.731% |
Beta | 0.98% | 0.958% |
Alpha | -1.737% | 0.84% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Dhaval Joshi | Kamal Gada |
Total AUM | ₹361932 Cr | ₹870 Cr |
Funds Managed | 55 | 1 |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 6.75 | 1.35 |
Large Cap | 34.78 | 28.87 |
Mid Cap | 37.07 | 26.26 |
Small Cap | 21.39 | 43.53 |
Sector Allocation
Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 5.74 | 0.45 |
Healthcare | 93.46 | 98.22 |
Basic Materials | 0.8 | 1.33 |
Top Comparisons
Franklin India Government Securities Fund - Growth
3Y Returns6.6%
Nippon India Gilt Securities Fund -Growth Plan - Growth Option
3Y Returns7.76%
Nippon India Corporate Bond Fund - Growth Plan - Growth Option
3Y Returns7.62%
Canara Robeco CorpoRate Bond Fund - Regular Plan - Growth Option
3Y Returns6.37%
Kotak Equity Opportunities Fund - Growth
3Y Returns17.65%
Sundaram Large and Midcap Fund Regular Plan - Growth
3Y Returns14.96%
DSP Banking & PSU Debt Fund - Regular Plan - Growth
3Y Returns7.28%
Sundaram Banking and PSU Debt Fund Regular Plan - Growth
3Y Returns7.02%